Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia

Schizophrenia Research

Volumn 25, Issue 1, 1997, Pages 1-10

  Berman, Ileana ^a,b   Viegner, Barbara ^b   Merson, Amalia ^b   Allan, Edward ^b   Pappas, Demetra ^a   Green, Alan I ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Negative symptoms; Neuropsychological deficits; Positive symptoms; Schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; AGED; ATTENTION; CHRONIC DISEASE; COGNITION DISORDERS; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DELUSIONS; DEPRESSION; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0031009774     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(96)00098-9     Document Type: Article

References (45)

1. Addington J, Addington D, Maticka-Tyndale E (1991) Cognitive Functioning and positive and negative symptoms in schizophrenia. Schizophr Res 5, 123-134.
2. Andreasen NC, Olsen S (1982) Negative v positive schizophrenia. Arch Gen Psychiatry 39, 789-794.
3. Andreasen NC, Nasrallah Z, Dunn VD, Olson SC, Grove WM, Ehrhardt JC, Koffman JA, Crossett JHW (1986) Structural abnormalities in the frontal system in schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry 43, 136-144.
4. Arndt S, Alliger RJ, Andreasen NC (1991) The distinction of positive and negative symptoms: the failure of a two-dimensional model. Br J Psychiatry 158, 317-322.
5. Benton AL, Hamsher K (1976) Multilingual Aphasia Examination. Iowa City, Iowa: University of Iowa.
6. Bornstein RA, Schwarzkopf SB, Olson SC, Nasrallah HA (1992) Third-ventricle enlargement and neuropsychological deficit in schizophrenia. Biol Psychiatry: 31, 954-961.
7. Carpenter WT, Buchanan RW, Kirkpatrick B, Taminga C, Wood F (1993) Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry 50, 825-831.
8. Chapman LJ, Chapman JP (1978) The measurement of differential deficit. J Abnormal Psychol 14, 303-311.
9. Cleghorn JM (1990) Regional brain metabolism during auditory hallucinations in chronic schizophrenia. Br J Psychiatry 157, 562-570.
10. Cleghorn JM, Garnett ES, Nahmias C, et al (1989) Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res 28, 119-133.
11. Crow TJ (1985) The two-syndrome concept: origins and current status. Schizophr Bull 11, 471-486.
12. Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, Losonczy MF, Keefe RSE, Katz S, Frecska E (1995) Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 152, 197-207.
13. Davis J (1975) Comparative doses of and costs of antipsychotic medications. Arch Gen Psychiatry 48, 181-190.
14. DeLisi LE, Buchsbaum MS, Holcomb HH, Langston KC, King AC, Kessler R, Pickar D, Carpenter WT Jr, Morihisa JM, Margolin R, Weinberger DR (1989) Increased temporal lobe glucose use in chronic schizophrenic patients. Biol Psychiatry 25, 835-851.
15. DeQuardo JR, Tandom R, Goldman R, Meador-Woodruff JH, Giroux-McGrath M, Brunberg JA, Kim L (1994) Ventricular enlargement, neuropsychological status, and premorbid function in schizophrenia. Biol Psychiatry 35, 517-524.
16. Ebmeier KP, Blackwood DHR, Murray C, Souza V, Walker M, Dougall N, Moffoot APR, O'Carroll RE, Goodwin GM (1993) Single-photon emission computed tomography with Tc-99m exametazime in unmedicated schizophrenic patients. Biol Psychiatry 33, 487-495.
17. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini-Mental State': a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12, 189-198.
18. Geraud G, Arne-Bes MC, Guell A (1987) Reversibility of hemodynamic hypofrontality in schizophrenia. J Cereb Blood Flow Metab 7, 9-12.
19. Green M, Walker E (1986) Attentional performance in positive and negative symptom schizophrenia. J Nerv Ment Dis 174, 208-213.
20. Goldberg TE, Gold J (1995) In: Bloom F and Kupfer D (Eds) Neurocognitive Functioning in Patients with Schizophrenia. Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, pp. 1245-1257.
21. Gunther W (1992) MRI-SPECT and PET-EEG findings on brain dysfunction in schizophrenia. Prog NeuroPsychopharmacol Biol Psychiatry 16, 445-462.
22. Heaton RK (1981) The WCST (manual). Odessa, FL: Psychological Assessment Resources.
23. Jastak S, Wilkinson GS (1984) Wide Range Achievement Test - Revised: administration manual. Wilmington, DE: Jastak Associates.
24. Kay SR (1991) Positive and Negative Syndromes in Schizophrenia: Assessment and Research. New York: Brunner/Mazel.
25. Kay SR, Fizbein A, Opler LA (1987) The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull 13, 261-276.
26. Keefe RSE (1995) The contribution of neuropsychology to psychiatry. Am J Psychiatry 152, 6-15.
27. Keilp JG, Sweeney JA, Jacobsen P, Solomon C, Louis St. L, Deck M, Frances A, Mann JJ (1988) Cognitive impairment in schizophrenia: specific relations to ventricular size and negative symptomatology. Biol Psychiatry 24, 47-55.
28. Milner B (1963) Effects of different brain lesions on card sorting. Arch Neurol 9, 100-110.
29. Mirsky AF (1988) Research on schizophrenia in the NIMH Laboratory of Psychology and Psychopathology, 1954-1987. Schizophr Bull 14, 151-156.
30. Opler LA, Kay SR, Rosado V, Lindenmayer JP (1987) Positive and negative syndromes in schizophrenic inpatients. J Nerv Ment Disorders 172, 317-325.
31. Paulman RG, Devous MD Sr, Gregory RR, Herman JH, Jennings L, Bonte FJ, Nasrallah HA Raese JD (1990) Hypofrontality and cognitive impairment in schizophrenia: dynamic single photon tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry 27, 377-399.
32. Reitan RM, Wolfson D (1985) The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press.
33. Robinson AL, Heaton RK, Lehman RAW, Stilson DW (1980) The utility of Wisconsin Card Sorting Test in detecting and localizing frontal lobe lesions. J Consult Clin Psychol 48, 605-614.
34. Rosse RB, Schwartz BL, Mastropado J, Goldberg RL, Deutsch SI (1991) Subtype diagnosis in schizophrenia and its relation to neuropsychological and computerized tomography measures. Biol Psychiatry 30, 63-72.
35. Seidman LJ, Yurgelun-Todd D, Kremen WS, Woods BT, Goldstein JM, Faraone SV, Tsuang MT (1994) Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia. Biol Psychiatry 35, 235-246.
36. Stolar N, Berenbaum H, Banich MT, Barch D (1994) Neuropsychological correlates of alogia and affective flattening in schizophrenia. Biol Psychiatry 35, 164-172.
37. Strauss M (1993) Relations of symptoms to cognitive deficits in schizophrenia. Schizophr Bull 19, 215-231.
38. Volkow ND, Wolf AP, van Gelder P, Brodie JD, Overall JE, Cancro R, Gomez-Mont F (1987) Phenomenological correlates of metabolic activity in 18 patients with schizophrenia. Am J Psychiatry 144, 151-158.
39. Walker E, Harvey P (1986) Positive and negative symptoms in schizophrenia: attentional performance correlates. Psychopathology 19, 294-302.
40. Walker E, Lewine R (1988) The positive/negative symptom distinction in schizophrenia. Validity and etiologic relevance. Schizophr Res 1, 315-328.
41. Wechsler D (1945) A standardized clinical scale for clinical use. J Psychol 19, 87-95.
42. Wechsler D (1981) Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation, New York: Harcourt Brace Jovanovich.
43. Weinberger DR (1987) Implications of normal brain development for pathogenesis of schizophrenia. Arch Gen Psychiatry 44, 660-669.
44. Weinberger DR, Berman KF, Zec RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43, 114-125.
45. Yates WR, Swayze VW, Andreasen NC (1990) Neuropsychological effect of global and focal cerebral atrophy in schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol 3, 98-106.